Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by quinlashon Mar 27, 2024 6:18pm
169 Views
Post# 35956732

RE:RE:a $3 ish uptick in shareprice

RE:RE:a $3 ish uptick in sharepriceThe reverse split occurred in 2023, it's behind us now and I'm surprised some still dwell on it.  Had you researched the topic you would have realized the R/S improves the EPS numbers and greatly reduces the outstanding sharecount. Canopy now sits on the lowest sharecount within it's peers and I will say within the cannabis sector.

Canopy has Canopy Medical in Germany, it's established and already selling into that market space.  The CEO has literally stated market potential in his interviews which can be found on YouTube.

It's shocking to think anyone is waiting for research to be dolled out on a forum but that's what I am seeing here.

Here's the reality. You can give a man a fish or teach him to fish. If no one will teach you then you're going to have to learn on your own.  Start learning and speculating on what Germany means to this company. Learn fundamentals and how to compare stocks.  

The US Fed is finally promoting cannabis again. If you think the uptick is tied to Germany then what the heck do you think will happen when Kamala Harris speaks on the subject again ?

IMHO you will do well to learn patience













<< Previous
Bullboard Posts
Next >>